D2 | Abstract 11
Annual NUTRIM Symposium 18 November 2020
APPLIED SCIENCE
Control Crohn Safe with episodic adalimumab monotherapy as first line treatment study (CoCroS): a study protocol
L.M. Janssen1,2, L. Brandts3, M.A. Joore3,4, A.A.M. Masclee1, D.M.A.E. Jonkers2, M.J. Pierik1
1 Maastricht University Medical Center+, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands.
2 Maastricht University Medical Center+, NUTRIM - School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
3 Maastricht University Medical Center+, Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht, The Netherlands.
4 Maastricht University, CAPHRI – School for Care and Public Health Research Institute, Maastricht, The Netherlands.
NUTRIM | School of Nutrition and Translational Research in Metabolism
NUTRIM aims to contribute to health maintenance and personalised medicine by unraveling lifestyle and disease-induced derangements in metabolism and by developing targeted nutritional, exercise and drug interventions. This is facilitated by a state of the art research infrastructure and close interaction between scientists, clinicians, master and PhD students.
www.maastrichtuniversity.nl/nutrim